Background of the Invention
Field of the Invention
[0001] The present invention relates to medical devices and, more particularly, to methods
and devices for forming a percutaneous channel. In one application, the present invention
relates to a minimally invasive procedure to insert an orthopedic fixation or stabilization
implant into the body, such as a formed
in situ spinal stabilization rod.
Description of the Related Art
[0002] The vertebrae and associated connective elements are subject to a variety of diseases
and conditions which cause pain and disability. Among these diseases and conditions
are spondylosis, spondylolisthesis, vertebral instability, spinal stenosis and degenerated,
herniated, or degenerated and herniated intervertebral discs. Additionally, the vertebrae
and associated connective elements are subject to injuries, including fractures and
torn ligaments and surgical manipulations, including laminectomies.
[0003] The pain and disability related to these diseases, conditions, injuries and manipulations
often result from the displacement of all or part of a vertebra from the remainder
of the vertebral column. A variety of methods have been developed to restore the displaced
vertebrae or portions of displaced vertebrae to their normal position and to fix them
within the vertebral column. For example, open reduction with screw fixation is one
currently used method. The surgical procedure of attaching two or more parts of a
bone with pins, screws, rods and plates requires an incision into the tissue surrounding
the bone and the drilling of one or more holes through the bone parts to be joined.
Due to the significant variation in bone size, configuration, and load requirements,
a wide variety of bone fixation devices have been developed in the prior art. In general,
the current standard of care relies upon a variety of metal wires, screws, rods, plates
and clamps to stabilize the bone fragments during the healing or fusing process. These
methods, however, are associated with a variety of disadvantages, such as morbidity,
high costs, lengthy in-patient hospital stays and the pain associated with open procedures.
[0004] Therefore, devices and methods are needed for repositioning and fixing displaced
vertebrae or portions of displaced vertebrae which cause less pain and potential complications.
Preferably, the devices are implantable through a minimally invasive procedure.
[0005] In addition, a wide variety of diagnostic or therapeutic procedures involve the introduction
of a device through a natural or artificially created access pathway. A general objective
of access systems which have been developed for this purpose, is to minimize the cross-sectional
area of the puncture, while maximizing the available space for the diagnostic or therapeutic
instrument. These procedures include, among others, a wide variety of laproscopic
diagnostic and therapeutic interventional procedures. Accordingly, a need remains
for access technology which allows a device to be percutaneously passed through a
small diameter tissue tract, while accommodating the introduction of relatively large
diameter instruments.
Summary of the Invention
[0006] A percutaneous access sheath is provided according to an aspect of the present invention.
In one application, the percutaneous access sheath is used to facilitate the insertion
of an orthopedic fixation or stabilization implant that is formed
in situ, such as a spinal stabilization rod.
[0007] The percutaneous access sheath may be used in conjunction with a deployment catheter,
which is provided with a balloon at its distal end. The percutaneous access sheath
has a proximal section and a variable diameter distal section. The deployment catheter
may be disposed within the percutaneous access sheath such that the balloon is positioned
within the distal section of the percutaneous access sheath.
[0008] The distal section of the percutaneous access sheath is restrained in a first, small
diameter by a releasable restraint such as a perforated insertion sheath. The distal
section of the percutaneous access sheath is creased, folded inwards and inserted
into a distal section of the insertion sheath. This gives the percutaneous access
sheath a smaller cross-sectional profile, facilitating its insertion.
[0009] The percutaneous access sheath is inserted as packaged above. Following insertion,
the insertion sheath may be torn away along its perforations. To facilitate this the
balloon may be partially inflated, expanding the distal section of the percutaneous
access sheath sufficiently to tear the insertion sheath along its perforations. After
the insertion sheath is removed, the balloon may be fully inflated to distend the
distal section of the percutaneous access sheath to its full cross-sectional profile.
Afterwards, the balloon may be deflated to allow the removal of the deployment catheter,
leaving the percutaneous access sheath in place.
[0010] In one embodiment where the percutaneous access sheath is used to facilitate the
insertion of an orthopedic spinal stabilization implant that is formed
in situ, a percutaneous access sheath may advantageously be first inserted through the portals
of adjacent bone anchors, by the method described above. This provides a smooth channel
to facilitate the passage of another deployment catheter carrying an inflatable orthopedic
fixation device at its distal end.
[0011] Other applications of the percutaneous access sheath include a variety of diagnostic
or therapeutic clinical situations which require access to the inside of the body,
through either an artificially created or natural body lumen.
Brief Description of the Drawings
[0012]
Figure 1 is a side elevational view of a percutaneous access sheath.
Figure 2 is a side elevational view of a insertion sheath.
Figure 3 illustrates the percutaneous access sheath in a reduced cross-sectional configuration
and inserted into the insertion sheath.
Figure 4 is a side elevational view of an access sheath expansion catheter.
Figure 5 is an enlarged view of the distal end of the expansion catheter.
Figure 6 is an enlarged view of the proximal end of the expansion catheter.
Figure 7 illustrates the percutaneous access sheath assembly, with the expansion catheter
inserted into the structure illustrated in Figure 3.
Figure 8 is a side elevational view of a bone anchor.
Figure 9 is a side elevational view of the bone anchor of Figure 8, rotated 90° about
its longitudinal axis.
Figure 10 is a longitudinal cross-sectional view of the bone anchor of Figure 9.
Figure 11 is a side elevational view of an alternative embodiment of a bone anchor.
Figure 12-15 illustrate one embodiment of a method of threading a guide wire through
the portals of bone anchors that have been implanted into adjacent vertebrae in a
vertebral column.
Detailed Description of the Preferred Embodiment
[0013] Figure 1 is an overview of the percutaneous access sheath 100. It generally comprises
an elongate tubular body with an axial lumen, and is designed to provide percutaneous
access to a diagnostic or treatment site in the body. The elongate tubular body has
a proximal section and a distal section 110. The length of these two sections can
be varied according to clinical need, as will be understood by those skilled in the
art with reference to this disclosure. The distal section 110 is expandable from a
first, smaller cross-sectional profile to a second, larger cross-sectional profile.
The first, smaller cross-sectional profile of the distal section 110 eases its insertion
into the percutaneous treatment site. After insertion, the distal section 110 is expanded
to a second, larger cross-sectional profile to provide a larger passageway for surgical
instruments to reach the percutaneous treatment site.
[0014] In the illustrated embodiment, the percutaneous access sheath 100 is made of a double-layered
co-extruded tubing 102, with an inner layer 104 and an outer layer 106. The inner
layer 104 defines a lumen 108. The inner layer 104 extends further distally than the
outer layer 106, such that the distal section 110 of the tubing 102 is of a single
layer, the inner layer 104. The inner layer 104 may be made of PTFE and the outer
layer 106 may be made of HDPE. Other suitable materials, such as nylon, PEBAX or PEEK,
may be used for either layer.
[0015] In this embodiment, the distal section 110 is creased, folded inwards, and collapsed
from a larger to a smaller cross-sectional profile to ease its insertion. As discussed
below, in one application of the invention, the distal section 110 is inserted through
adjacent bone screws or anchors. Its length is thus determined by the distance between
such adjacent bone screws, and is generally in the range of 4-12cm. The proximal end
112 of the tubing 102 is flared and fitted onto a handle 114. A distal cap 116 may
be threaded onto the handle 114 to secure the proximal end 112 of the tubing 102.
Additionally a proximal cap 118 may be threaded onto the handle 114. The overall length
of the tubing 102 depends on the distance between the insertion and treatment locations,
and is generally in the range of 15-60cm for orthopedic fixation surgery of the vertebrae.
In the illustrated embodiment the length of the tubing is approximately 20cm, with
the distal section 110 accounting for approximately half of that length.
[0016] Figure 2 is an overview of the insertion sheath 200. It is preferably made of a thin,
smooth and flexible material. The insertion sheath 200 has a proximal section and
a distal, restraint section 210. The restraint section 210 has a smaller cross-sectional
profile than the proximal section of the insertion sheath 200. The restraint section
210 is adapted to restrain the distal section 110 of the percutaneous access sheath
100 in its smaller cross-sectional profile. This is achieved by inserting the percutaneous
access sheath 100 into the insertion sheath 200 such that the distal section 110 of
the percutaneous access sheath 100 lies within the restraint section 210 of the insertion
sheath 200.
[0017] In the illustrated embodiment, the insertion sheath 200 may be made of PTFE. The
proximal end 202 of the insertion sheath 200 terminates at a pull tab 204, which may
be formed by a threaded luer lock. The insertion sheath 200 is provided with a slit
206 near its proximal end 202. The insertion sheath 200 tapers at a first tapering
point 208 into a restraint section 210, which tapers again into the distal tip 212.
As discussed above, the restraint section 210 restrains the distal section 110 of
the percutaneous access sheath 100 in its smaller cross-sectional profile. Thus the
length of the restraint section 210 is approximately the same as or slightly longer
than the distal section 110, and generally falls in the range of 4-13cm.
[0018] The diameter of the restraint section 210 is preferably smaller than the diameter
of the eye of the bone screw used, as discussed below. The insertion sheath 200 may
be perforated or otherwise provided with a tear line distally from the first tapering
point 208 to its distal tip 212. The distance between the slit 206 and the distal
tip 212 is generally approximately equal to or slightly shorter than the length of
the tubing 102, and thus is generally in the range of 12-57cm. In the illustrated
embodiment this distance is approximately 15cm, and the overall length of the insertion
sheath 200 is approximately 24cm.
[0019] Figure 3 illustrates the percutaneous access sheath 100 inserted into the insertion
sheath 200 via the slit 206 provided near its proximal end 202. The diameter of the
restraint section 210 of the insertion sheath 200 is smaller than the diameter of
the distal section 110 of the tubing 102. The distal section 110 is creased and folded
inwards to decrease its effective diameter, and inserted into the restraint section
210. As discussed above, the restraint section 210 restrains the distal section 110
of the percutaneous access sheath 100 in its smaller cross-sectional profile. The
restraint section 210 is approximately the same length as or just longer than the
distal section 110. Thus inserted, the distal section 110 extends to a point just
proximal of the distal tip 212 of the insertion sheath 200.
[0020] In certain embodiments an insertion sheath 200 may not be necessary if the distal
section 110 of the percutaneous access sheath 100 is made of a stretchable material
that may be stretched from a first, smaller cross-sectional profile to a second, larger
cross-sectional profile. In these embodiments the outer surface of the distal section
110 is preferably made of a smooth material to facilitate the insertion of the percutaneous
access sheath 100 into a treatment site.
[0021] Figure 4 is an overview of the deployment catheter 300. It is provided with an expansion
element such as balloon 310 at its distal end. The deployment catheter 300 is inserted
into the lumen 108 of the percutaneous access sheath 100 such that the balloon 310
is arranged within the distal section 110. The balloon 310 may be inflated to expand
the distal section 110 from its first, smaller cross-sectional profile to its second,
larger cross-sectional profile following the insertion of the percutaneous access
sheath 100 into a treatment site.
[0022] An inner tube 302 extends the entire length of the deployment catheter 300. A guide
wire lumen 304 is defined by the interior of the inner tube 302. The deployment catheter
300 can travel along a guide wire extending through the guide wire lumen 304. The
inner tube 302 carries coaxially on its exterior an outer tube 306. The outer tube
306 terminates proximally into the distal end of a handle 308, and distally into the
proximal end of a balloon 310. The balloon 310 may be made of PET. The handle 308
may be provided with an optional support tube 312 extending from its distal end and
over a proximal section of the outer tube 306, to increase the rigidity of the deployment
catheter 300 during insertion. This support tube 312 may be made of aluminum.
[0023] Figure 5 is an enlarged view of the distal end of the deployment catheter 300. Both
the inner tube 302 and the guide wire lumen 304 extend through the distal end 314
of the balloon 310. The inner tube 302 carries coaxially on its exterior a marker
ring 316 near the distal end 314 of the balloon 310. Alternatively the marker ring
316 may be carried by the distal end 314 of the balloon 310. The marker ring 316 is
preferably made of gold, tantalum, or another radio-opaque material. Additional marker
rings may be provided in the balloon 310 to aid in visualizing its location. A balloon
inflation lumen 318, defined in the space between the inner tube 302 and the outer
tube 306, communicates with the interior of the balloon 310. As discussed above, the
balloon 310 may be inflated to expand the distal section 110 of the percutaneous access
sheath 100 from its first, smaller cross-sectional profile to its second, larger cross-sectional
profile. Thus the length of the balloon 310 is approximately equal to or slightly
longer than the length of the distal section 110. In the illustrated embodiment the
length of the balloon 310 is approximately 10cm.
[0024] Figure 6 is an enlarged view of the proximal end of the deployment catheter 300.
Both the inner tube 302 and the guide wire lumen 304 extend through the proximal end
of the handle 308. The balloon inflation lumen 318, defmed in the space between the
inner tube 302 and the outer tube 306, opens into a port 320 in the handle 308. A
stopper 322 supports the inner tube 302 within the handle 308 and prevents the balloon
inflation lumen 318 from communicating with the space 324 in the main branch of the
handle 308. Thus only the port 320 communicates via the balloon inflation lumen 318
with the interior of the balloon. A pump may be connected to the port 320 to inflate
or deflate the balloon. To enable visualization of the state of the balloon, it may
be inflated with contrast media.
[0025] Figure 7 illustrates the percutaneous access sheath assembly 150. The percutaneous
access sheath assembly 150 comprises the percutaneous access sheath 100, the insertion
sheath 200 and the deployment catheter 300. It is assembled by inserting the deployment
catheter 300 into the percutaneous access sheath 100 and inserting the percutaneous
access sheath 100 into the insertion sheath 200 such as via the slit 206 or other
proximal opening provided near its proximal end 202. The balloon 310 of the deployment
catheter 300 is deflated, folded and inserted into the distal section 110 of the access
sheath 100. The distal section 110, as discussed above, is creased and folded inwards
to decrease its effective diameter, and inserted into the restraint section 210 of
the insertion sheath 200. As discussed, the balloon 310 is approximately the same
length as or just longer than the distal section 110 and the restraint section 210.
[0026] Figures 8-11 illustrate one embodiment of a bone anchor 410 as mentioned above. It
is provided with at least one connector 422 at or near its proximal end (or top end,
as illustrated). This connector 422 is used to engage an orthopedic spinal stabilization
implant that is formed
in situ, as discussed below. The connector 422 is preferably an aperture 422, to achieve a
more secure engagement. In one embodiment the percutaneous access sheath 100 extends
through the apertures 422 of two or more bone anchors 410 to establish a passageway
to facilitate the insertion of a formed
in situ orthopedic spinal stabilization implant.
[0027] An embodiment with two bone anchors is now described. The percutaneous access sheath
100 is extended through the aperture 422 of a first bone anchor 410, then through
the aperture 422 of a second bone anchor 410. The first bone anchor 410 is preferably
implanted within a first bone. The second bone anchor 410 may be implanted within
the second bone. The bones may be adjacent vertebral bodies or vertebrae, or first
and second vertebrae spaced apart by one or more intermediate vertebrae. The clinical
procedure is described in further detail below.
[0028] The bone anchors 410 of Figures 8-11 are made of a biocompatible material such as
titanium or stainless steel. Alternatively, the bone anchors 410 may be made of a
composite material. The bone anchors 410 may also be made of a suitable medical grade
polymer. In one embodiment, the bone anchors 410 have a length between about 40 mm
and 60 mm, preferably about 50 mm. However, the actual length is dependent on the
location of the fracture, size of patient, etc.
[0029] The bone anchor 410 comprises a proximal portion 412 having a proximal end 414 and
a distal portion 416 having a distal end 418. The proximal portion 412 typically comprises
a head 420 and a portal 422. In a preferred embodiment, the head 420 comprises a proximal
portion 424 configured to mate with the tip of a screwdriver. The head 420 may comprise
a standard or Phillips slot for mating with the screwdriver. A variety of slot configurations
are also suitable, such as hexagonal, Torx, rectangular, triangular, curved, or any
other suitable shape. The bone anchor of Figure 11 has a raised platform 434 having
a plurality of substantially flat sides, such as a hexagonal platform, configured
to mate with a corresponding depression in the distal end of a screwdriver. Platform
434 may come in a variety of shapes suitable mating with a screwdriver.
[0030] The portal 422 of the bone anchor 410 may extend through the head 420 and is generally
between about 4 mm and 8 mm in diameter, preferably about 6 mm to about 8 mm in diameter.
The portal 422 may be of any suitable shape; however, the portal 422 is preferably
round to facilitate the insertion of the percutaneous tube 100 as well as the
in situ forming orthopedic spinal stabilization implant.
[0031] The distal portion 416 of the bone anchor 410 typically comprises threads 426 and
a sharp tip 428. The bone anchor 410 also preferably comprises a central lumen 430
extending coaxially through the length of the bone anchor 410 from its proximal end
414 to its distal end 418 and configured to receive a guidewire. The bone anchor 410
may also include one or more perforations 432, as shown in Figure 11. These perforations
432 are in communication with the central lumen 430 of the bone anchor 410. The perforations
432 may be aligned axially, as illustrated, or may be staggered axially. The perforations
432 permit bone to grow into bone anchor 410, stabilizing bone anchor 410 within the
bone. Additionally, bone matrix material such as a hydroxyapatite preparation can
be injected into the central lumen 430 and through the perforations 432 to promote
bone in-growth.
[0032] The method of using the percutaneous access sheath 100 to facilitate the insertion
of an orthopedic spinal stabilization implant formed
in situ according to one aspect of the present invention is described in the following figures.
In this embodiment a smooth channel is first established between two or more adjacent
bone anchors to facilitate the passage of another deployment catheter carrying an
inflatable orthopedic fixation device at its distal end. While the method is disclosed
and depicted with reference to only two vertebrae, one of which is either unstable,
separated or displaced and the other of which is neither unstable, separated or displaced,
the method can also be applied to three or more vertebrae simultaneously. Further,
the method can be used to stabilize the L5 vertebrae, using the cranial-ward portion
of the sacrum as the "vertebrae" with which L5 is anchored. Although the method is
disclosed and depicted as applied on the left side of the vertebral column, the method
can also be applied on the right side of the vertebral column or, preferably, on both
sides of the vertebral column, as will be understood by those skilled in the art with
reference to this disclosure. Other applications include the stabilization of other
bones and skeletal elements of the body.
[0033] Figure 12 illustrates bone anchors 410 that have been inserted through the periosteal
surface and into the anterior vertebral body or another suitable portion of the vertebrae
500 and 502. As discussed above, bone matrix material such as a hydroxyapatite preparation
can be injected into the central lumen 430 of a bone anchors 410 and through its perforations
(not visible in this figure) to promote bone in-growth. The bone anchors 410 are arranged
such that their portals 422 are substantially coaxial in relation to each other.
[0034] A hollow needle 436 is inserted percutaneously and advanced into the portal 422 of
one of the bone anchors 410, with the aid of fluoroscopy. The hollow needle 436 may
be 16 or 18 gauge. While the hollow needle 436 is shown engaging the bone screw 410
in the cranial-ward vertebrae 502, it can alternatively first engage the bone screw
410 in the caudal-ward vertebrae 500, as will be understood by those skilled in the
art with reference to the disclosure. Figure 13 is an enlarged view of the distal
end of the hollow needle 436. A semi-rigid guide wire 438 is introduced through the
lumen of the hollow need 436 and the portal 422 of the bone anchor 410 in the cranial-ward
vertebrae 502. The hollow needle 436 preferably has a Tuohy needle tip which causes
the guide wire 438 to exit the hollow needle 436 perpendicularly to the central lumen
430 of the bone anchor 410, or coaxially with the axis of the portal 422 of the bone
anchor 410. Alternatively, the bending of the guide wire 438 through the portal 422
of the bone anchor 410 may be accomplished by an angled-tip modified Ross needle or
another suitable structure as will be understood by those skilled in the art with
reference to the disclosure.
[0035] Figure 14 illustrates an optional guide wire directing device 440, according to one
aspect of the present invention, inserted percutaneously between the bone anchors
410. The guide wire directing device 440 may have a forked end used to direct the
guide wire 438 through the portal 422 of the bone anchor 410 in the caudal-ward vertebrae
500. In another embodiment a guide wire capture device 442, such as a snare or forceps,
may be inserted percutaneously caudal to the portal 422 of the bone anchor 410 in
the caudal-ward vertebrae 500. The guide wire capture device 442 engages the distal
end of the guide wire 438 after the guide wire 438 has passed through portal 422 of
the bone anchor 410 in the caudal-ward vertebrae 500, and pulls it through the skin
dorsally, so that both ends of the guide wire 438 are secured.
[0036] Figure 15 illustrates the guide wire 438 in place after the procedure described above
in Figures 12-14.
[0037] The guide wire 438 may be inserted into the guide wire lumen 304 of the deployment
catheter 300 of the percutaneous access sheath assembly 150. The entire assembly 150
may travel over the guide wire 438 until its distal tapered portion is inserted through
the portals 422 of the bone anchors 410. The insertion sheath 200, which is on the
exterior of the percutaneous access sheath assembly 150, facilitates the insertion
because of its smooth, low profile exterior. As discussed above, it may be made of
PTFE.
[0038] Following the insertion of the percutaneous access sheath assembly 150, the insertion
sheath 200 is removed. This may be accomplished by pulling on the pull tab 204 and
tearing the insertion sheath 200 along the perforations, crease line, or other structure
for facilitating tearing provided along its restraint section 210. This may be facilitated
by first partially inflating the balloon 310 of the deployment catheter 300. As discussed
above, the balloon 310 is arranged within the distal section 110 of the percutaneous
access sheath 100, which is itself arranged within the restraint section 210 of the
insertion sheath 200. Thus, inflating the balloon 310 causes the distal section 110
of the percutaneous access sheath 100 to expand, tearing the restraint section 210
of the insertion sheath 200 along its perforations.
[0039] After the removal of the insertion sheath 200, the balloon 310 may be fully inflated
to expand the distal section 110 of the percutaneous access sheath to its full cross-sectional
profile. Afterwards the balloon 310 may be deflated to ease the removal of the deployment
catheter 300. As discussed above, the inflation and deflation of the balloon 310 may
be done via a pump connected to the port 320 of the deployment catheter 300, and preferably
with contrast media being pumped, to better convey the state of the balloon.
[0040] Thus the percutaneous access sheath 100 is inserted through the portals 422 of the
bone anchors 410. The establishment of this smooth channel through the portals 422
of the bone anchors 410 facilitates the passage of another deployment catheter carrying
an inflatable orthopedic fixation device at its distal end. An example of such a deployment
catheter with an inflatable orthopedic fixation device at its distal end as well as
the associated anchors and methods are disclosed in United States Patent Application
Serial No.
10/161,554 filed on May 31, 2002, the disclosure of which is hereby incorporated by reference in its entirety.
[0041] Although the present invention has been described in terms of certain preferred embodiments,
other embodiments of the invention including variations in dimensions, configuration
and materials will be apparent to those of skill in the art in view of the disclosure
herein. In addition, all features discussed in connection with any one embodiment
herein can be readily adapted for use in other embodiments herein. The use of different
terms or reference numerals for similar features in different embodiments does not
imply differences other than those which may be expressly set forth. Accordingly,
the present invention is intended to be described solely by reference to the appended
claims, and not limited to the preferred embodiments disclosed herein.
1. System for providing percutaneous access comprising:
a percutaneous access sheath (100) comprising an elongate tubular structure, at least
a portion of said elongate tubular structure being expandable from a first, smaller
cross-sectional profile to a second, greater cross-sectional profile;
a releasable sheath (200) carried by the access sheath to restrain at least a portion
of said elongate tubular structure in said first, smaller cross-sectional profile;
and
a bone anchor (410) attachable to a vertebral body, the bone anchor including an aperture
(422) through which said elongate tubular structure is insertable.
2. System as claimed in claim 1 further comprising an implant which is introduceable
through said tubular structure when the tubular structure has the second, greater
cross-sectional profile.
3. System as claimed in claim 2 wherein said implant comprises a formed in place orthopaedic
implant.
4. System as claimed in any of the preceding claims further comprising second bone anchor
(410) attachable to a second vertebral body, the elongate tubular structure being
insertable through said second bone anchor.
5. System as claimed in any of the preceding claims further comprising a hollow needle
(436) insertable into the aperture (422) of said bone anchor (410) and through which
needle a guidewire (438) can be inserted.
6. System as claimed in claim 5 further comprising said guidewire (438) over which the
percutaneous access sheath may travel until a distal tapered portion thereof is inserted
through the aperture(s) (422) of the bone anchor(s) (410).
7. System as claimed in any of the preceding claims further comprising an inflatable
balloon to expand said portion from said first, smaller cross-sectional profile to
said second, greater cross-sectional profile.
8. System as claimed in claim 7 wherein said balloon is carried by a balloon catheter
which is axially moveably positionable within the percutaneous access sheath.
9. System as claimed in any of the preceding claims wherein said releasable sheath comprises
a peel away sheath.
10. A method, practised on a non-living substrate, of providing percutaneous access, said
method comprising:
percutaneously inserting an elongate tubular structure through an aperture in a bone
anchor, the tubular structure having a first, smaller cross-sectional profile;
removing a tubular restraint from the elongate tubular structure; and
expanding said elongate tubular structure from said first, smaller cross-sectional
profile to a second, greater cross-sectional profile.
11. The method of claim 10 additionally comprising the step of inflating a balloon to
expand said elongate tubular structure from said first, smaller cross-sectional profile
to said second, greater cross-sectional profile.
12. The method of claim 11 wherein the inflating a balloon step is accomplished using
a balloon catheter positioned within the tubular body.
13. The method of claim 11 further comprising the step of removing the balloon from the
tubular structure following the expanding step.
14. The method of claim 10 further comprising the step of introducing an implant through
the tubular structure when the tubular structure is in the second, greater cross-sectional
profile.
15. The method of claim 14 wherein the implant comprises a formed in place orthopaedic
implant.